Website
http://dataportal.arc.gov.au/NCGP/API/grants/IH220100017
Funding Status
Active
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals. Radiopharmaceuticals are emerging as next generation medical technologies for addressing complex health challenges, and their manufacture offers significant economic benefit to Australia. The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technologies combining innovations in biotechnology and pharmaceutical science. The program addresses industry-led challenges for translation of biologics as molecular radiopharmaceuticals, building capacity in biomanufacturing, radiobiology and radiochemistry. The program establishes a dedicated manufacturing pipeline, future-proofing production and securing supply chain of next generation medical technologies.Funded Activity Details
Start Date: 09-2023
End Date: 09-2028
Funding Scheme: Industrial Transformation Research Hubs
Funding Amount: $4,808,669.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Medical molecular engineering of nucleic acids and proteins | Pharmaceutical sciences | Pharmacology and pharmaceutical sciences | Nanomanufacturing |
ANZSRC Socio-Economic Objective (SEO)
